Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment regimen description
| Line of therapy and medication used | Number of patients (%) |
|---|---|
| First-line | 60 (100) |
| Sunitinib | 45 (75) |
| Pazopanib | 8 (14) |
| Sorafenib | 2 (3) |
| Everolimus | 2 (3) |
| Temsirolimus | 2 (3) |
| Axitinib | 1 (2) |
| Second-line | 40 (66.7) |
| Everolimus | 20 (33.3) |
| Sunitinib | 9 (15) |
| Sorafenib | 9 (15) |
| Axitinib | 2 (3) |
| Third-line | 13 (21.7) |
| Everolimus | 5 (38) |
| Sunitinib | 3 (23) |
| Sorafenib | 3 (23) |
| Axitinib | 2 (16) |
| Fourth-line | 5 (8.3) |
| Sunitinib | 2 (3.3) |
| Sorafenib | 2 (3.3) |
| Axitinib | 1 (1.7) |
